Agilent to Acquire Resolution Bioscience
The acquisition of Resolution Bioscience complements and expands Agilent’s capabilities in NGS-based cancer diagnostics.
Read More
Search Results for: lung cancer
Advances in Liquid Biopsy
Developing technology ushers in a new era in precision oncology.
Read More
Liquid Biopsy Tests Now Available
The FDA has approved two comprehensive genomic profiling liquid biopsy tests for use in supporting doctors with their treatment decision-making.
Read More
Liquid Biopsy for Colorectal Cancer Could Guide Therapy for Tumors
The study suggests that such liquid biopsies could help personalize treatment for oligometastatic colorectal cancer.
Read More
Blood Testing for Organ Injury from Covid-19
Researchers have developed a blood test that uses cell-free DNA to gauge the damage that covid-19 inflicts on cells, tissues, and organs, and could help aid in the development of new therapies.
Read More